4.8 Article

Improvement of cognitive function in wild-type and Alzheimer's disease mouse models by the immunomodulatory properties of menthol inhalation or by depletion of T regulatory cells

Journal

FRONTIERS IN IMMUNOLOGY
Volume 14, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2023.1130044

Keywords

immunomodulation; menthol; methimazole; olfactory system; Treg cells; central nervous system; cognitive capacity; Alzheimer's disease

Categories

Ask authors/readers for more resources

This study explores the complex network of interactions between the olfactory, immune, and central nervous systems. It investigates the effects of an immunostimulatory odorant, menthol, on immune response and cognitive capacity in healthy and Alzheimer's Disease Mouse Models. The findings suggest that menthol enhances immune response and improves cognitive capacity, with downregulation of IL-1 beta and IL-6 mRNA in the brain. Long-term exposure to menthol prevents cognitive impairment in the Alzheimer's mouse model and depletion/inhibition of T regulatory cells also improves cognitive capacity. These results highlight the potential of odors and immune modulators as therapeutic agents for CNS-related diseases.
A complex network of interactions exists between the olfactory, immune and central nervous systems. In this work we intend to investigate this connection through the use of an immunostimulatory odorant like menthol, analyzing its impact on the immune system and the cognitive capacity in healthy and Alzheimer's Disease Mouse Models. We first found that repeated short exposures to menthol odor enhanced the immune response against ovalbumin immunization. Menthol inhalation also improved the cognitive capacity of immunocompetent mice but not in immunodeficient NSG mice, which exhibited very poor fear-conditioning. This improvement was associated with a downregulation of IL-1 beta and IL-6 mRNA in the brain ' s prefrontal cortex, and it was impaired by anosmia induction with methimazole. Exposure to menthol for 6 months (1 week per month) prevented the cognitive impairment observed in the APP/PS1 mouse model of Alzheimer. Besides, this improvement was also observed by the depletion or inhibition of T regulatory cells. Treg depletion also improved the cognitive capacity of the APP(NL-G-F/NL-G-F) Alzheimer ' s mouse model. In all cases, the improvement in learning capacity was associated with a downregulation of IL-1b mRNA. Blockade of the IL-1 receptor with anakinra resulted in a significant increase in cognitive capacity in healthy mice as well as in the APP/PS1 model of Alzheimer ' s disease. These data suggest an association between the immunomodulatory capacity of smells and their impact on the cognitive functions of the animals, highlighting the potential of odors and immune modulators as therapeutic agents for CNS-related diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available